LP
PFE icon

LMR Partners’s Pfizer PFE Stock Holding History

LMR Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28M Buy
260,990
+221,001
+553% +$5.78M 0.02% 571
2026
Q1 		$1.12M Sell
39,989
-466,562
-92% -$12.4M ﹤0.01% 960
2025
Q4 		$12.6M Buy
506,551
+5,151
+1% +$130K 0.02% 297
2025
Q3 		$12.8M Buy
501,400
+1,400
+0.3% +$34.6K 0.06% 258
2025
Q2 		$12.1M Sell
500,000
-94,467
-16% -$2.2M 0.09% 237
2025
Q1 		$15.1M Sell
594,467
-41,526
-7% -$1.09M 0.14% 172
2024
Q4 		$16.9M Buy
635,993
+633,726
+27,954% +$17.2M 0.14% 141
2024
Q3 		$65.6K Buy
+2,267
New +$66.1K ﹤0.01% 1064
2022
Q1 		– Sell
-135,914
Closed -$7.05M – 1327
2021
Q4 		$8.03M Buy
+135,914
New +$6.73M 0.08% 187
2021
Q2 		– Sell
-62,142
Closed -$2.25M – 1275
2021
Q1 		$2.25M Buy
+62,142
New +$2.21M 0.06% 306
2020
Q4 		– Sell
-7,156
Closed -$249K – 599
2020
Q3 		$249K Buy
+7,156
New +$251K 0.01% 328
2020
Q1 		– Sell
-30,621
Closed -$1.14M – 399
2019
Q4 		$1.14M Buy
+30,621
New +$1.09M ﹤0.01% 199
2019
Q2 		– Sell
-7,119
Closed -$287K – 547
2019
Q1 		$287K Sell
7,119
-63,381
-90% -$2.54M 0.01% 313
2018
Q4 		$2.92M Buy
+70,500
New +$2.93M 0.14% 84
2017
Q2 		– Sell
-21,735
Closed -$705K – 674
2017
Q1 		$705K Buy
21,735
+11,331
+109% +$357K 0.07% 166
2016
Q4 		$321K Buy
10,404
+3,819
+58% +$117K 0.05% 278
2016
Q3 		$212K Buy
+6,585
New +$220K 0.02% 321
2016
Q1 		– Sell
-30,282
Closed -$927K – 414
2015
Q4 		$927K Buy
+30,282
New +$953K 0.3% 69

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LMR Partners's PFE Position: Q2 2026 in Review

LMR Partners increased its Pfizer (PFE) stake by 553% in Q2 2026, buying an estimated $5.78M and bringing the position to 260,990 shares worth $6.28M. The position accounts for 0.02% of the portfolio, ranked #571.

LMR Partners first reported a position in PFE in Q4 2015 and has held it in 18 quarters since. The position peaked at $16.9M in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LMR Partners held 260,990 shares of Pfizer worth $6.28M as of Q2 2026.
  • LMR Partners bought 221,001 Pfizer shares in Q2 2026, an estimated $5.78M.
  • Pfizer made up 0.02% of LMR Partners's portfolio in Q2 2026, its #571 holding.
  • LMR Partners first reported a position in Pfizer in Q4 2015 and has held it in 18 quarters since.
  • LMR Partners's Pfizer position peaked at $16.9M in Q4 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.